Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pfizer prepares new beta3-adrenoceptor agonists

May 13, 1998

Novartis begins phase III trial with Aredia in prostate cancer patients

May 12, 1998

Cysteine protease inhibitors synthesized at SKB claimed for osteoporosis, arthritis, periodontitis

May 11, 1998

Initial results in the development of gene therapy for OI reported by NIH

May 11, 1998

Serono introduces Geref for treatment/diagnosis of GHD

May 8, 1998

CP-336156: nonsteroidal estrogen agonist/antagonist with a better profile than estrogen

May 8, 1998

Osiris awarded patent for the use of MSCs in bone marrow regeneration

May 8, 1998

FDA approves improved oral contraceptive agent

May 7, 1998

ArQule and Beth Israel enter collaboration for osteopenic disease drug discovery

May 7, 1998

OCT: suppression of PTH secretion in mouse model of severe parathyroid hyperplasia

May 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...